Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
EMBL European Molecular Biology Laboratory
EMBL European Molecular Biology Laboratory
Activities:
Media
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Bio-Rad joins EMBL’s Corporate Partnership Programme
Corporate Partnership Programme is designed to create long-term relationships between EMBL scientists and its corporate partners, like Bio-Rad
Finance
EMBL Ventures portfolio company, Luxendo, acquired by Bruker
The acquisition, just one and a half years after the company’s creation, allows wider application of Luxendo's Single Plane Illumination Microscopy
Research & Development
Sartorius enters into a corporate partnership programme with the European Molecular Biology Laboratory (EMBL)
Sartorius and EMBL join forces to offer advanced training and science education, aiming to connect industry to academia
Research & Development
Merck and the European Molecular Biology Laboratory agree three-year drug discovery collaboration
Focus on cancer metabolism aims to deliver novel therapeutic targets and biomarkers
Research & Development
Open access platform accelerates drug discovery and development
A web interface to help researchers find therapeutic targets for new and repurposed medicines is now available from the Centre for Therapeutic Target Validation
Research & Development
EMBL-EBI appoints Joint Directors
Ewan Birney and Rolf Apweiler move up from Joint Associate Directors on 1 July
Regulatory
Consortium creates active molecule data standard
Researchers can enter discoveries in a public template and shared database
Subscribe now